Skip to main content
. 2022 Nov 30;11(23):3865. doi: 10.3390/cells11233865

Table 2.

Immunomodulating agents applied to xenotransplantation.

Sources Immunomodulating Agents Component Mechanism Pig-to-NHP Xenotransplantation Reference
Under investigation Anti-CD154 Ab Blockade of CD40−CD154 Kidney, heart, islets [145,146,147]
Cobra venom factor Inhibition of complement system Islets [34]
Anti-CD40 Ab Blockade of CD40−CD154 costimulatory signal Kidney, heart, islets [145,147,148]
FDA non-approved, commercially available Eculizumab Blockade of the C5b-9 MAC Pancreas [149]
Etanercept Anti-TNF-alpha inhibitor Islets [150]
Intravenous immunoglobulin Modulating antigen presenting cell activity and complement activation Hearts [151,152]
IL-1 receptor antagonist IL-1 inhibitor Heart [153]
IL-6 receptor antagonist IL-6 inhibitor Islet, Kidney, Heart [154,155]
FDA approved for transplantation Tacrolimus Inhibition of the enzyme calcineurin by binding of FKBP-12 Pancreas [156,157]
Mycophenolic acids Inhibition of the lymphocyte cycle by blocking inosine monophosphate dehydrogenase Kidney, heart, islets [158,159]

Abbreviation: Ab, antibody; NHP, non-human primate; MAC, membrane attack complex; TNF, tumor necrosis factor; IL, interleukin; FDA, the Food and Drug Administration.